BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21714602)

  • 1. Myths and truths of growth hormone and testosterone therapy in heart failure.
    Nguyen CT; Aaronson A; Morrissey RP; Agarwal M; Willix RD; Schwarz ER
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):711-20. PubMed ID: 21714602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone and testosterone in heart failure therapy.
    Agarwal M; Naghi J; Philip K; Phan A; Willix RD; Schwarz ER
    Expert Opin Pharmacother; 2010 Aug; 11(11):1835-44. PubMed ID: 20486829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone therapy: treatment of metabolic disturbances in heart failure.
    Naghi JJ; Philip KJ; DiLibero D; Willix R; Schwarz ER
    J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):14-23. PubMed ID: 21097668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone and heart failure.
    Malkin CJ; Channer KS; Jones TH
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):262-8. PubMed ID: 20404724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial.
    Malkin CJ; Pugh PJ; West JN; van Beek EJ; Jones TH; Channer KS
    Eur Heart J; 2006 Jan; 27(1):57-64. PubMed ID: 16093267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone therapy in heart failure: where are we now?
    Demers C; McKelvie RS
    Congest Heart Fail; 2003; 9(2):84-90. PubMed ID: 12671339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for sarcopenia and muscle weakness in older people.
    Borst SE
    Age Ageing; 2004 Nov; 33(6):548-55. PubMed ID: 15385272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials.
    Ramahi TM; Lee FA
    Cardiol Clin; 1995 Feb; 13(1):5-26. PubMed ID: 7796432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of dilated cardiomyopathy with recombinant human growth hormone].
    Osterziel KJ; Markus U; Willenbrock R; Strohm O; Dietz R
    Z Kardiol; 1997 Oct; 86(10):803-11. PubMed ID: 9454447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of inodilators.
    Dei Cas L; Metra M; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S60-71. PubMed ID: 2483442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermal hydrotherapy improves quality of life and hemodynamic function in patients with chronic heart failure.
    Michalsen A; Lüdtke R; Bühring M; Spahn G; Langhorst J; Dobos GJ
    Am Heart J; 2003 Oct; 146(4):728-33. PubMed ID: 14564334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ibopamine--clinical results].
    Kleber FX
    Z Kardiol; 1991; 80 Suppl 8():71-6. PubMed ID: 1686695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal Replacement Therapy in Heart Failure: Focus on Growth Hormone and Testosterone.
    Salzano A; D'Assante R; Lander M; Arcopinto M; Bossone E; Suzuki T; Cittadini A
    Heart Fail Clin; 2019 Jul; 15(3):377-391. PubMed ID: 31079696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of testosterone and nandrolone on cardiac function: a randomized, placebo-controlled study.
    Chung T; Kelleher S; Liu PY; Conway AJ; Kritharides L; Handelsman DJ
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):235-45. PubMed ID: 17223994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of growth hormone therapy in children after cardiac transplantation.
    Mital S; Andron A; Lamour JM; Hsu DT; Addonizio LJ; Softness B
    J Heart Lung Transplant; 2006 Jul; 25(7):772-7. PubMed ID: 16818119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.